Brain/Neuro Cancer: Recurrent Glioblastoma Clinical Trials

Showing 1-8 of 8 items
1.
2.
3.
4.
  • Pembrolizumab +/- Bevacizumab for Recurrent GBM
  • In this research study, the investigators are looking to determine the effectiveness of Pembrolizumab (MK-3475) when given with bevacizumab or when given alone for the treatment of recurrent glioblastoma multiforme (GBM). This study will also test the safety and tolerability of Pembrolizumab (MK-3475) when given alone or with bevacizumab.
  • Diagnoses: Brain/Neuro Cancer: Recurrent Glioblastoma
  • Status: Recruiting
5.
6.
7.
8.
Showing 1-8 of 8 items
  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms